Details of the Drug-Related molecule(s) Interaction Atlas
General Information of Drug (ID: DM09LY4)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
3709-08-8; alpha,alpha-Dimethyl-gamma-butyrolactone; 3,3-dimethyldihydrofuran-2(3h)-one; 3,3-dimethyloxolan-2-one; 2(3H)-Furanone, dihydro-3,3-dimethyl-; Dihydro-3,3-dimethyl-2(3H)-furanone; 2,2-Dimethyl-4-butyrolactone; UPVAIJPDWVTFKT-UHFFFAOYSA-N; Butyric acid, 2,2-dimethyl-4-hydroxy-, g-lactone; Dimethylbutanolid; alpha-DMgBL; NSC1094; AC1L3STF; AC1Q6HQD; 2,2-dimethylbutyrolactone; Furanone, dihydrodimethyl-; a,a-Dimethyl- -butyrolactone; SCHEMBL149596; CHEMBL33962; CTK2A6366; DTXSID30190584; MolPort-009-198-442
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule-Related Drug Atlas
Molecule-Related Drug Atlas
Molecule Type:
DTT Drug Status:
Approved Drug(s) Clinical Trial Drug(s) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug(s) Targeting Gamma-aminobutyric acid receptor (GAR)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Molecular Interaction Atlas | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
References